raloxifene
Clinical studies on postmenopausal osteoporotic women on raloxifene as compared       with placebo show a significant decrease in the rate of newly diagnosed breast       cancers.
Clinical studies on postmenopausal osteoporotic women on  @SUBJECT$  as  @PREDICAT$        with  @OBJECT$  show a significant decrease in the rate of newly diagnosed breast       cancers.